Home

myocarditis cases per year

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19  Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR

Myocarditis and pericarditis - rare adverse reactions to Comirnaty (Pfizer  COVID-19 vaccine)
Myocarditis and pericarditis - rare adverse reactions to Comirnaty (Pfizer COVID-19 vaccine)

COVID-19 infection more likely than vaccines to cause rare cardiovascular  complications — Nuffield Department of Primary Care Health Sciences,  University of Oxford
COVID-19 infection more likely than vaccines to cause rare cardiovascular complications — Nuffield Department of Primary Care Health Sciences, University of Oxford

KoreaMed Synapse
KoreaMed Synapse

Association Between COVID-19 and Myocarditis Using Hospital-Based  Administrative Data — United States, March 2020–January 2021 | MMWR
Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 | MMWR

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19  Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR

While rare, myocarditis after COVID-19 vaccination is more common in young  men
While rare, myocarditis after COVID-19 vaccination is more common in young men

Frontiers | Global, Regional, and National Burden of Myocarditis and  Cardiomyopathy, 1990–2017
Frontiers | Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990–2017

JCM | Free Full-Text | Epidemiological Impact of Myocarditis
JCM | Free Full-Text | Epidemiological Impact of Myocarditis

COVID-19 Vaccine Myocarditis∗ : Cautious Reassurance in an Era of Dynamic  Uncertainty | Journal of the American College of Cardiology
COVID-19 Vaccine Myocarditis∗ : Cautious Reassurance in an Era of Dynamic Uncertainty | Journal of the American College of Cardiology

Reporting of immune checkpoint inhibitor-associated myocarditis - The Lancet
Reporting of immune checkpoint inhibitor-associated myocarditis - The Lancet

The effects of gender and age on occurrence of clinically suspected  myocarditis in adulthood | Heart
The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood | Heart

Systematic analysis of drug-associated myocarditis reported in the World  Health Organization pharmacovigilance database | Nature Communications
Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database | Nature Communications

Long-Term Outcome of Fulminant Myocarditis as Compared with Acute  (Nonfulminant) Myocarditis | NEJM
Long-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) Myocarditis | NEJM

Association Between COVID-19 and Myocarditis Using Hospital-Based  Administrative Data — United States, March 2020–January 2021 | MMWR
Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 | MMWR

Vaccines and Related Biological Products Advisory Committee June 14, 2022  Meeting Presentation - Update on myocarditis following
Vaccines and Related Biological Products Advisory Committee June 14, 2022 Meeting Presentation - Update on myocarditis following

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM

Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination  Compared With Viral Myocarditis - ScienceDirect
Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis - ScienceDirect

The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy  - ScienceDirect
The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy - ScienceDirect

SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based  cohort study | The BMJ
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study | The BMJ

French study on cardiovascular disease incidence during COVID pandemic and  vaccination campaign
French study on cardiovascular disease incidence during COVID pandemic and vaccination campaign

Occurrence and Features of Childhood Myocarditis: A Nationwide Study in  Finland | Journal of the American Heart Association
Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland | Journal of the American Heart Association

Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in  Pediatric Heart Transplant Recipients? | Circulation: Heart Failure
Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? | Circulation: Heart Failure

Trends in the Incidence of In-Hospital Mortality, Cardiogenic Shock, and  Utilization of Mechanical Circulatory Support Devices in Myocarditis  (Analysis of National Inpatient Sample Data, 2005–2014) - ScienceDirect
Trends in the Incidence of In-Hospital Mortality, Cardiogenic Shock, and Utilization of Mechanical Circulatory Support Devices in Myocarditis (Analysis of National Inpatient Sample Data, 2005–2014) - ScienceDirect

Occurrence and Features of Childhood Myocarditis: A Nationwide Study in  Finland | Journal of the American Heart Association
Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland | Journal of the American Heart Association

Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination  Compared With Viral Myocarditis | Journal of the American College of  Cardiology
Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis | Journal of the American College of Cardiology

Trends in myocarditis incidence, complications and mortality in Sweden from  2000 to 2014 | Scientific Reports
Trends in myocarditis incidence, complications and mortality in Sweden from 2000 to 2014 | Scientific Reports

Quantifying the risks versus benefits of the Pfizer COVID-19 vaccine in  Australia: a Bayesian network analysis | medRxiv
Quantifying the risks versus benefits of the Pfizer COVID-19 vaccine in Australia: a Bayesian network analysis | medRxiv

Frontiers | Global, Regional, and National Burden of Myocarditis and  Cardiomyopathy, 1990–2017
Frontiers | Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990–2017

Myocarditis and Pericarditis Following Vaccination with COVID-19 mRNA  Vaccines in Ontario: December 13, 2020 to November 21, 202
Myocarditis and Pericarditis Following Vaccination with COVID-19 mRNA Vaccines in Ontario: December 13, 2020 to November 21, 202